Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now exceedingly rare in the ...

NEW YORK, NY (Aug. 10) -- Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now ...

NEW YORK - A blood mismatch between a pregnant woman and her fetus may double the risk of schizophrenia, according to the results of a new study. But all of the children in the study were born before ...

In March, the U.S. FDA reported a major shortage of Rhogam, the anti-D immune globulin most widely used to prevent Rh factor incompatibility in pregnancy. Without treatment, second and subsequent ...

UCLA scientists have discovered that infants possessing a cell protein called Rhesus (Rh) factor that their mothers lack are twice as likely to develop schizophrenia in young adulthood. Reported in ...

Background/Aim: The optimal management of anaemia of prematurity is still unknown. Therapeutic approaches include delayed cord clamping and early treatment with protein and iron supplements and ...

Only half of pregnant women worldwide who need a 50-year-old treatment that prevents an often-fatal disease in fetuses and newborns receive it, researchers have found. Only half of pregnant women ...